Results 161 to 170 of about 49,420 (307)
Formulation of microparticulate dosage forms for enhancing nasal macromolecular compound delivery
PhD (Pharmaceutics), North-West University, Potchefstroom Campus Therapeutic macromolecules are relatively large molecules (> 500 Da) that possess pharmacological characteristics that can be used for the treatment of various diseases. However, from a drug delivery point of view, many of these compounds exhibit unfavorable pharmacokinetic properties due
openaire +1 more source
Abstract Background The epidemiology of equine influenza (EI) in the United Kingdom has not been systematically described since the 2019 epidemic. Objectives To summarise UK EI surveillance (2020–2024), quantify outbreak seasonality and assess movement‐related sources. Study Design Retrospective observational analysis of national surveillance and horse
Fleur Whitlock +2 more
wiley +1 more source
Abstract Background Antimicrobials are commonly prescribed for the treatment of equine asthma, despite limited evidence supporting their use. Tracheal wash (TW) bacterial culture results are known to influence antimicrobial prescription decisions. Objectives To determine whether a positive TW bacterial culture in horses with asthma is associated with ...
Laurence Leduc +2 more
wiley +1 more source
Ex-post assessment of merger effects: the case of Pfizer and Pharmacia (2003) [PDF]
The paper studies the effects of the Pfizer and Pharmacia (2003) merger on competition in the Swiss pharmaceutical market and compares the assessment of the Swiss Competition Commission (COMCO) with the post-merger market developments.
Beschorner, Patrick +2 more
core
ADF is prepared as a cell‐free bio‐membrane from autologous adipose ECM using simple physical techniques inspired by “papermaking”. It boasts superior properties and facilitates tissue regeneration through Trem2+ macrophages‐mediated angiogenesis. ADF can be stored long‐term for personalized medicine, offering insights into autologous ECM preservation ...
Mengmeng Hou +8 more
wiley +1 more source
Clinical applications of esketamine: Current status and future perspectives. [PDF]
Li H, Deng J, Liu T, Zhang Y.
europepmc +1 more source
Our findings underscore a multi‐targeting strategy for severe airway inflammation that multi‐targeting nanoformulation C‐TA1 markedly attenuated airway inflammation by (1) cfDNA elimination to alleviate neutrophilic/eosinophilic inflammation mediated by the TLR9 pathway, (2) prevention of RONS‐induced tissue injury and inflammatory response, (3 ...
Ming Liu +10 more
wiley +1 more source

